We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you.
Oops! Something went wrong while submitting the form.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Serialization is not one-size-fits-all. With varying mandates across the U.S., EU, Asia, and the Middle East, companies must navigate a complex web of requirements. Are you prepared for global compliance?
Find out how LSPedia is pushing forward the world of traceability. Our monthly newsletter is your guide to the serialized supply chain – from DSCSA compliance to industry events and technological advances – and beyond.
In this edition: A regulator’s take on DSCSA, LSPedia achieves FedRAMP In-Process designation, pharmacists earn CE credits through hands-on DSCSA training, and more!
In this edition: AI & ML are Revolutionizing Regulatory Affairs, Optimizing Supply Chains with ASNs, LSPedia CEO, Riya Cao Launches Executive Newsletter and more!
DSCSA Enforcement Begins May 27 – 6 Critical Actions to Protect Your Shipments FDA enforcement is around the corner. LSPedia outlines six key actions—like validating EPCIS connections and resolving exceptions—to help manufacturers and repackagers stay compliant and keep shipments moving.
LSPedia’s Daniel MacKinnon met with leading pharma manufacturers in India frustrated by outdated systems and poor support. His latest blog explains why many are making the switch to LSPedia.
Matt Vincent, Director of Sales at LSPedia, breaks down the FDA’s DSCSA exemptions and their importance as the stabilization period ends on November 27, 2024.
LSPedia has introduced a new Waivers, Exceptions, and Exemptions (WEEs) resource page, providing essential answers to pressing questions from those considering requesting a waiver for additional time to achieve DSCSA compliance and how to manage WEEs going forward with trading partners.
In the pharmaceutical industry, maintaining a resilient and sustainable supply chain is paramount for ensuring product integrity, regulatory compliance, and operational efficiency.